홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

1,2-Dichloroethane → Formate

HRID 418331
노트
인쇄 미리보기

반응식

HRID 418331 반응식
C([O:5][C:6]([N:8]1[CH2:13][CH2:12][CH2:11][CH:10]([CH2:14][CH2:15][C:16]([OH:18])=O)[CH2:9]1)=[O:7])(C)(C)C.C(Cl)CCl.C1C=CC2N(O)N=NC=2C=1.CN1CCOCC1.[NH2:40][C:41]1[CH:42]=[C:43]([CH2:47][C:48]([NH:50][C:51]2[CH:56]=[CH:55][C:54]([O:57][CH3:58])=[C:53]([O:59][CH3:60])[CH:52]=2)=[O:49])[CH:44]=[CH:45][CH:46]=1>ClCCl.CN(C=O)C>[CH3:60][O:59][C:53]1[CH:52]=[C:51]([NH:50][C:48]([CH2:47][C:43]2[CH:42]=[C:41]([NH:40][C:16](=[O:18])[CH2:15][CH2:14][CH:10]3[CH2:11][CH2:12][CH2:13][NH:8][CH2:9]3)[CH:46]=[CH:45][CH:44]=2)=[O:49])[CH:56]=[CH:55][C:54]=1[O:57][CH3:58].[CH:6]([O-:7])=[O:5]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

9

반응물 5

HCID 111,2-DichloroethaneHCID 79724-MethylmorpholineHCID 757711-HydroxybenzotriazoleHCID 27568241-Boc-piperidin-3-yl-propionic acidHCID 28712232HCID 28712232, 화합물

생성물 2

HCID 283Formate수율 412.5%
HCID 25055320
HCID 25055320, 화합물

시약·촉매·용매 2

HCID 6228Dimethylformamide용매HCID 6344Dichloromethane용매

실험 절차

3-Nitrophenylacetic acid (136 mg, 0.75 mmol), EDC (240 mg, 1.25 mmol) and HOBt (135 mg, 1 mmol) were combined in a reaction vial, and DMF (1 mL) was added, followed by N-methylmorpholine (0.137 mL, 1.25 mmol). The resulting solution was agitated for 1 h, after which time 3,4-dimethoxyaniline (115 mg, 0.75 mmol) was added and the reaction mixture was agitated overnight. The reaction mixture was then diluted with 6 mL dichloromethane, and the resulting mixture was washed with 1 N HCl (2×2 mL), NaHCO3 (satd. aq., 2×2 mL), and brine (1×2 mL), dried, and the solvents were evaporated to 216 mg of a dark oil. The product was purified by preparative HPLC using an acetonitrile/water/formic acid gradient to provide 36 mg (15% yield) of the intermediate N-(3,4-dimethoxy-phenyl)-2-(3-nitro-phenyl)-acetamide. This intermediate (36 mg, 0.114 mmol) was dissolved in methanol (1 mL) and ammonium formate (69 mg, 1.1 mmol) and then Pd/C (5 mg) was added. The reaction vial was sealed and heated to 45° C. overnight. The reaction mixture was filtered, and the mother liquors were diluted with ethyl acetate (10 mL). This mixture was washed with water (2×5 mL) and brine (1×5 mL), dried and concentrated to provide 10 mg (31% yield) of the desired intermediate 2-(3-amino-phenyl)-N-(3,4-dimethoxy-phenyl)-acetamide, which was used directly. Subsequently, 3-(2-carboxy-ethyl)-piperidine-1-carboxylic acid tert-butyl ester (12.9 mg, 0.05 mmol), EDC (11.5 mg, 0.06 mmol) and HOBt (8.1 mg, 0.06 mmol) were combined in a reaction vial, and DMF (1 mL) was added, followed by N-methylmorpholine (0.007 mL, 0.06 mmol). The resulting solution was agitated for 30 minutes, after which time the intermediate prepared above, 2-(3-amino-phenyl)-N-(3,4-dimethoxy-phenyl)-acetamide (10 mg, 0.035 mmol) was added. The reaction mixture was agitated overnight, then diluted with 5 mL dichloromethane, and the resulting mixture was washed with 1N HCl (2×2 mL), NaHCO3 (saturated aqueous, 1×2 mL), and brine (1×2 mL), dried, and concentrated to 19 mg (72%) of an amber oil, which was dissolved in dichloromethane (1 mL) and treated with SCX (136 mg, 0.12 mmol). The resulting mixture was agitated overnight. The reaction mixture was then filtered and the solids were washed with dichloromethane (2×2 mL) and methanol (2×2 mL). The product was eluted with NH3 in methanol (7 N, 2×2 mL), and the solvents were evaporated. The resulting residue was purified by preparative HPLC using an acetonitrile/water/formic acid gradient providing the title compound as a formate salt (6.5 mg, 38% yield), MS analysis electrospray, 426 (M+H).

후처리

  1. additionwas added
  2. customafter which time the intermediate prepared above
  3. stirringThe reaction mixture was agitated overnight
  4. washthe resulting mixture was washed with 1N HCl (2×2 mL), NaHCO3 (saturated aqueous, 1×2 mL), and brine (1×2 mL)
  5. customdried
  6. concentrationconcentrated to 19 mg (72%) of an amber oil, which
  7. dissolutionwas dissolved in dichloromethane (1 mL)
  8. additiontreated with SCX (136 mg, 0.12 mmol)
  9. stirringThe resulting mixture was agitated overnight
  10. filtrationThe reaction mixture was then filtered
  11. washthe solids were washed with dichloromethane (2×2 mL) and methanol (2×2 mL)
  12. washThe product was eluted with NH3 in methanol (7 N, 2×2 mL)
  13. customthe solvents were evaporated
  14. customThe resulting residue was purified by preparative HPLC

출처 및 근거

ORD 기록
ord-4c6a35b954a2488597e90d156f578688
출처 데이터셋
uspto-grants-2012_01
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08093266B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트